August 20, 2026 at 10:37 AM ET
Bruce Power gets go-ahead for isotope processing
Canada's nuclear regulator has authorised Bruce Power to operate the on-site facility to carry out an important step in the production process for lutetium-177, used in the treatment of prostate cancer and in targeted therapies in precision medicine.





